In its recommendations, the AAP opposes:
·      Marijuana use by children and adolescents (aged through 21 years) given evidence on the negative health and brain development effects.
·      Medical marijuana use outside the regulatory process of the US Food and Drug Administration (FDA), although it recognizes it may be an option for children with life-limiting or severely debilitating conditions for whom current therapies are inadequate.
·      Legalization of marijuana because of the potential harms to children and adolescents.
·      Use of smoked marijuana because smoking causes lung damage.